Across TCGA pan-cancer cohorts, NUTM2B Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated NUTM2B data layer compared with 25 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher NUTM2B Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NUTM2B expression acts as an unfavorable survival marker.

THYM are the cancer types where NUTM2B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: NUTM2B tumor-vs-normal RNA expression · all NUTM2B data types